rs35704760

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_003227.4(TFR2):​c.1770C>T​(p.Asp590Asp) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00378 in 1,611,606 control chromosomes in the GnomAD database, including 84 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0035 ( 11 hom., cov: 33)
Exomes 𝑓: 0.0038 ( 73 hom. )

Consequence

TFR2
NM_003227.4 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: -4.30

Publications

4 publications found
Variant links:
Genes affected
TFR2 (HGNC:11762): (transferrin receptor 2) This gene encodes a single-pass type II membrane protein, which is a member of the transferrin receptor-like family. This protein mediates cellular uptake of transferrin-bound iron, and may be involved in iron metabolism, hepatocyte function and erythrocyte differentiation. Mutations in this gene have been associated with hereditary hemochromatosis type III. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]
TFR2 Gene-Disease associations (from GenCC):
  • hemochromatosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-100627489-G-A is Benign according to our data. Variant chr7-100627489-G-A is described in ClinVar as Benign. ClinVar VariationId is 21368.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00349 (531/152326) while in subpopulation SAS AF = 0.0141 (68/4830). AF 95% confidence interval is 0.0114. There are 11 homozygotes in GnomAd4. There are 272 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFR2NM_003227.4 linkc.1770C>T p.Asp590Asp splice_region_variant, synonymous_variant Exon 16 of 18 ENST00000223051.8 NP_003218.2 Q9UP52-1
TFR2NM_001206855.3 linkc.1257C>T p.Asp419Asp splice_region_variant, synonymous_variant Exon 13 of 15 NP_001193784.1 Q9UP52-2
LOC124901709XR_007060454.1 linkn.434-3667G>A intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFR2ENST00000223051.8 linkc.1770C>T p.Asp590Asp splice_region_variant, synonymous_variant Exon 16 of 18 1 NM_003227.4 ENSP00000223051.3 Q9UP52-1

Frequencies

GnomAD3 genomes
AF:
0.00348
AC:
529
AN:
152208
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.0527
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.00243
Gnomad OTH
AF:
0.00671
GnomAD2 exomes
AF:
0.00641
AC:
1571
AN:
245126
AF XY:
0.00693
show subpopulations
Gnomad AFR exome
AF:
0.00121
Gnomad AMR exome
AF:
0.00468
Gnomad ASJ exome
AF:
0.0547
Gnomad EAS exome
AF:
0.000332
Gnomad FIN exome
AF:
0.000339
Gnomad NFE exome
AF:
0.00318
Gnomad OTH exome
AF:
0.00785
GnomAD4 exome
AF:
0.00381
AC:
5559
AN:
1459280
Hom.:
73
Cov.:
40
AF XY:
0.00426
AC XY:
3089
AN XY:
725722
show subpopulations
African (AFR)
AF:
0.00135
AC:
45
AN:
33438
American (AMR)
AF:
0.00433
AC:
191
AN:
44102
Ashkenazi Jewish (ASJ)
AF:
0.0528
AC:
1376
AN:
26064
East Asian (EAS)
AF:
0.000177
AC:
7
AN:
39592
South Asian (SAS)
AF:
0.0143
AC:
1231
AN:
85956
European-Finnish (FIN)
AF:
0.000282
AC:
15
AN:
53248
Middle Eastern (MID)
AF:
0.0125
AC:
72
AN:
5762
European-Non Finnish (NFE)
AF:
0.00197
AC:
2189
AN:
1110818
Other (OTH)
AF:
0.00718
AC:
433
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
391
782
1173
1564
1955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00349
AC:
531
AN:
152326
Hom.:
11
Cov.:
33
AF XY:
0.00365
AC XY:
272
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41576
American (AMR)
AF:
0.00314
AC:
48
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0527
AC:
183
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5176
South Asian (SAS)
AF:
0.0141
AC:
68
AN:
4830
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10626
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.00243
AC:
165
AN:
68026
Other (OTH)
AF:
0.00664
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
24
47
71
94
118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00413
Hom.:
11
Bravo
AF:
0.00346
Asia WGS
AF:
0.00664
AC:
24
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemochromatosis type 3 Benign:2Other:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not provided Benign:2
Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TFR2: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary hemochromatosis Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.38
DANN
Benign
0.68
PhyloP100
-4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.29
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.29
Position offset: -31

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35704760; hg19: chr7-100225112; COSMIC: COSV56154261; COSMIC: COSV56154261; API